Skip to content
healthcare.dev

LANSOPRAZOLE

NDC 68382-771, LANSOPRAZOLE, tablet, orally disintegrating, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-771
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200816
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-771 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
68382-771-776838207717710 BLISTER PACK in 1 CARTON (68382-771-77) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (68382-771-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9b3869ad-f2f7-4954-b75c-5c23b8951635
  • NADAC price for package 68382077177

    GET /v1/drugs/nadac/68382077177

Use it

Look up 68382-771 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-771 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-771. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.